NIP
Nicholas Investment Partners’s Ascendis Pharma ASND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $455K | Buy |
+2,637
| New | +$455K | 0.04% | 203 |
|
|
2024
Q4 | – | Sell |
-8,474
| Closed | -$1.27M | – | 226 |
|
|
2024
Q3 | $1.27M | Sell |
8,474
-14,742
| -63% | -$2.2M | 0.12% | 177 |
|
|
2024
Q2 | $3.17M | Buy |
23,216
+5,232
| +29% | +$714K | 0.33% | 115 |
|
|
2024
Q1 | $2.72M | Buy |
17,984
+13,717
| +321% | +$2.07M | 0.28% | 129 |
|
|
2023
Q4 | $537K | Sell |
4,267
-166,342
| -97% | -$21M | 0.06% | 172 |
|
|
2023
Q3 | $16M | Hold |
170,609
| – | – | 1.19% | 29 |
|
|
2023
Q2 | $15.2M | Sell |
170,609
-80,778
| -32% | -$7.21M | 1.04% | 33 |
|
|
2023
Q1 | $27M | Buy |
251,387
+85,450
| +51% | +$9.16M | 2.05% | 12 |
|
|
2022
Q4 | $20.3M | Buy |
165,937
+28,383
| +21% | +$3.47M | 1.78% | 10 |
|
|
2022
Q3 | $14.2M | Buy |
137,554
+30,623
| +29% | +$3.16M | 1.32% | 23 |
|
|
2022
Q2 | $9.94M | Sell |
106,931
-80,470
| -43% | -$7.48M | 0.94% | 36 |
|
|
2022
Q1 | $22M | Buy |
187,401
+75,279
| +67% | +$8.83M | 1.56% | 12 |
|
|
2021
Q4 | $15.1M | Buy |
112,122
+84,988
| +313% | +$11.4M | 0.95% | 29 |
|
|
2021
Q3 | $4.33M | Buy |
+27,134
| New | +$4.33M | 0.32% | 110 |
|
|
2019
Q2 | – | Sell |
-4,643
| Closed | -$546K | – | 210 |
|
|
2019
Q1 | $546K | Buy |
+4,643
| New | +$546K | 0.05% | 204 |
|